Hypersensitivity to scopolamine in the elderly

@article{Flicker2005HypersensitivityTS,
  title={Hypersensitivity to scopolamine in the elderly},
  author={Charles Flicker and Steven H. Ferris and Michael J. Serby},
  journal={Psychopharmacology},
  year={2005},
  volume={107},
  pages={437-441}
}
Scopolamine hydrobromide, 0.43 mg/70 kg, was administered by subcutaneous injection to ten young and ten elderly subjects. A comprehensive neuropsychological test battery was used to assess the effects of scopolamine, as compared to placebo, on cognitive function. As previously reported for this group of young subjects, scopolamine significantly impaired performance on tests of recent memory and visuospatial praxis. The same effects were observed in the elderly subjects, but the magnitude of… 
Age-related decline in central cholinergic function demonstrated with scopolamine
TLDR
There was a significant overall correlation between age and scopolamine-impaired performances on psychomotor speed, short-term recall, visual tracking speed, visuo-motor coordination, and sequencing ability, and the results provide further evidence that cholinergically mediated cognitive functions show an increased sensitivity to scopolamines with age.
Dose-specific effects of scopolamine on canine cognition: Impairment of visuospatial memory, but not visuospatial discrimination
TLDR
The present results indicate that scopolamine-induced impairments of working memory in the dog can serve as a model of age-related cholinergic dysfunction and can be dissociated from scopolamines-induced deficits in discrimination performance and non-cognitive behaviors.
Increased Anticholinergic Challenge-Induced Memory Impairment Associated with the APOE-ɛ4 Allele in the Elderly: A Controlled Pilot Study
TLDR
Evidence is provided suggesting that the ɛ4 allele plays a significant role in increasing cognitive sensitivity to trihexyphenidyl and that a temporal component of memory consolidation may be especially vulnerable.
Anti-Amnesic Activity of Vitex Negundo in Scopolamine Induced Amnesia in Rats
TLDR
Results of the study have shown that V. negundo treated groups decrease the phenomenon of amnesia by increasing learning of memory through antioxidant effect and decreasing AChE activity.
Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjects.
TLDR
Most of the differences in response to scopolamine administration between young and older subjects could be explained by pharmacokinetic differences (lower clearance) and not to an enhanced sensitivity when corrected for exposure levels.
Scopolamine-induced “cholinergic stress test” in the elderly
TLDR
Scopolamine is a promising candidate for the management of PONV in adults as a first line monotherapy or in combination with other drugs, and might be helpful in preventing postoperative discharge nausea and vomiting owing to its long-lasting clinical effects.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 25 REFERENCES
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed
TLDR
The results support the conclusion reached in previous studies that the cognitive profile of scopolamine-injected young subjects is more similar to that of the nondemented elderly than to thatof Alzheimer's disease patients.
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.
TLDR
The results indicate that central nervous system functions such as cognition and certain elements of behavior are more sensitive to temporary cholinergic blockade in patients with DAT than in normal age-matched controls.
Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert
TLDR
The altered sensitivity to the mnemonic effects of cholinergic agents in the experimental group suggests that the cholin allergic neurons of the nucleus basalis of Meynert contribute to recognition memory.
Human memory and the cholinergic system. A relationship to aging?
TLDR
Comparisons of the memory and cognitive deficits induced by scopolamine with the performance of aged subjects revealed a marked similarity of pattern, and the possible theoretical explanations for the behavioral similarity seen with central cholinergic blockade and normal aging are discussed.
A visual recognition memory test for the assessment of cognitive function in aging and dementia.
TLDR
The present task was found to elicit significant differences in performance between young and non-demented aged subjects, between the non-Demented and demented elderly, and between demented subjects in the early and more advanced stages of senile dementia of the Alzheimer type (SDAT).
Acquisition and retention of categorized material in normal aging and senile dementia.
TLDR
The recognition test results suggest that recall deficits evidenced by both elderly groups are in large part due to faulty retrieval mechanisms, and has potential for memory assessment in clinical settings.
The cholinergic hypothesis of geriatric memory dysfunction.
Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed. An attempt has been made to
...
1
2
3
...